Bio-Images Drug Delivery Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Bio-Images Drug Delivery Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11082
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Bio-Images Drug Delivery Ltd (BDD) is an independent company that focuses on the development of modified and controlled release oral formulations. The company provides formulation development, troubleshooting, in vitro and in vivo testing and full technology transfer programs. It offers wide range of services such as clinical rescue, microdosing, generics development, controlled release, gamma scintigraphy and clinical and PK studies among others. The company’s OralogiK technology is a drug delivery system providing timed release, sustained release and the opportunity for complex bi- and tri-phasic release of one or multiple drugs. It provides clinical services such as study documentation design, protocol development and regulatory authority submission, through to close out and production of ICH GCP-compliant clinical study reports. BDD is headquartered in Glasgow, Scotland, the UK.

Bio-Images Drug Delivery Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Bio-Images Drug Delivery Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Bio-Images Drug Delivery Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Bio-Images Drug Delivery Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Bio-Images Drug Delivery Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Bio-Images Drug Delivery Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Bio-Images Drug Delivery Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Bio-Images Drug Delivery Raises USD2.8 Million in Venture Financing 10
Licensing Agreements 11
Bio-Images Drug Delivery Enters into Licensing Agreement with Cingulate Therapeutics 11
Novartis Pharma Enters into Licensing Agreement with Bio-Images Drug Delivery 12
Bio-Images Drug Delivery Ltd – Key Competitors 13
Bio-Images Drug Delivery Ltd – Key Employees 14
Bio-Images Drug Delivery Ltd – Locations And Subsidiaries 15
Head Office 15
Recent Developments 16
Corporate Communications 16
Oct 12, 2018: BDD Appoints Ex-AstraZeneca VP Joanne Kelley as Non-executive Director to the Board 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Bio-Images Drug Delivery Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Bio-Images Drug Delivery Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Bio-Images Drug Delivery Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Bio-Images Drug Delivery Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Bio-Images Drug Delivery Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Bio-Images Drug Delivery Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Bio-Images Drug Delivery Raises USD2.8 Million in Venture Financing 10
Bio-Images Drug Delivery Enters into Licensing Agreement with Cingulate Therapeutics 11
Novartis Pharma Enters into Licensing Agreement with Bio-Images Drug Delivery 12
Bio-Images Drug Delivery Ltd, Key Competitors 13
Bio-Images Drug Delivery Ltd, Key Employees 14

List of Figures
Bio-Images Drug Delivery Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Bio-Images Drug Delivery Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Bio-Images Drug Delivery Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Bio-Images Drug Delivery Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Bio-Images Drug Delivery Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Bio-Images Drug Delivery Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Bio-Images Drug Delivery Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Bio-Images Drug Delivery Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Bio-Images Drug Delivery Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Celsius Holdings, Inc.:戦略・SWOT・企業財務分析
    Celsius Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Celsius Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • PetVivo Holdings Inc (PETV):企業の製品パイプライン分析2018
    Summary PetVivo Holdings Inc (PetVivo Holdings), formerly Technologies Scan Corp, is a biomedical device company. The company offers licensing and commercialization of medical devices and therapeutics to treat pets and animals suffering from arthritis and other afflictions. Its products include Kush …
  • S&T Dynamics Co., Ltd.:戦略・SWOT・企業財務分析
    S&T Dynamics Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary S&T Dynamics Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Orsted AS (ORSTED):石油・ガス:M&Aディール及び事業提携情報
    Summary Orsted AS (Orsted) formerly Dong Energy A/S, is an integrated energy company that procures, produces, distributes and trades energy and energy related products. It generates electricity and heat using conventional fuel and wind energy sources. The company also develops, constructs, owns and …
  • Destination Maternity Corporation (DEST):企業の財務・戦略的SWOT分析
    Destination Maternity Corporation (DEST) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Oxford Nanopore Technologies Ltd:企業の戦略的SWOT分析
    Oxford Nanopore Technologies Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • ImmunoCellular Therapeutics Ltd (IMUC)-医療機器分野:企業M&A・提携分析
    Summary ImmunoCellular Therapeutics Ltd (IMCU) is a clinical-stage biotechnology company which develops immune-based therapies for the treatment of various cancers. The product pipeline of the company includes active immunotherapies and patented monoclonal antibodies. IMCU’s immunotherapies product …
  • Yokogawa Electric Corp (6841):石油・ガス:M&Aディール及び事業提携情報
    Summary Yokogawa Electric Corp (Yokogawa) is an industrial automation company. It manufactures and supplies products and solutions in measurement, control, and information technologies fields. The company’s product offering include differential pressure/pressure transmitters, flow meters, and proces …
  • Boralex Inc (BLX):電力:M&Aディール及び事業提携情報
    Summary Boralex Inc (Boralex) is a renewable energy company. It develops, builds, and operates renewable energy power facilities. The company’s asset portfolio includes wind, hydro, thermal, and solar projects. Boralex also has interests in various projects under development stages. Under long-term …
  • Schuco International KG:企業の戦略的SWOT分析
    Schuco International KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Petrobras Argentina SA:企業の戦略的SWOT分析
    Petrobras Argentina SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Emerson Electric Co.:戦略・SWOT・企業財務分析
    Emerson Electric Co. - Strategy, SWOT and Corporate Finance Report Summary Emerson Electric Co. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • RED HAT, INC.:企業の戦略・SWOT・財務情報
    RED HAT, INC. - Strategy, SWOT and Corporate Finance Report Summary RED HAT, INC. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Trustwave Holdings Inc:企業の戦略的SWOT分析
    Trustwave Holdings Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • SK Chemicals Co Ltd (006120):企業の財務・戦略的SWOT分析
    Summary SK Chemicals Co Ltd (SK Chemicals) is a chemical company that provides life sciences products and solutions. The company manufactures polyester and acetate yarns for textile, and industrial uses. Its copolyesters comprise ecozen, skygreen and skypets. SK Chemicals provides high-performance r …
  • Investec Private Bank (South Africa):企業の戦略・SWOT・財務情報
    Investec Private Bank (South Africa) - Strategy, SWOT and Corporate Finance Report Summary Investec Private Bank (South Africa) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Damodar Valley Corp:企業の戦略的SWOT分析
    Damodar Valley Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Berkshire Hathaway Energy:企業の戦略・SWOT・財務分析
    Berkshire Hathaway Energy - Strategy, SWOT and Corporate Finance Report Summary Berkshire Hathaway Energy - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • German Cancer Research Center-医療機器分野:企業M&A・提携分析
    Summary German Cancer Research Center (DKFZ) is a biomedical research institute that develops therapies for the treatment of cancer patients. The institute’s research programs include translational cancer research, cell biology and tumor biology, imaging and radiooncology, cancer risk factors and pr …
  • Zee Entertainment Enterprises Ltd (ZEEL):企業の財務・戦略的SWOT分析
    Summary Zee Entertainment Enterprises Ltd (Zee Entertainment), subsidiary of Essel Corporate Resources Pvt Ltd, is a global content company that offers media and entertainment services. The company offers regional languages domain with channels including Zee Marathi, Zee Talkies, Zee Bangla, Zee Ban …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆